Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
To better understand how medication status and task demands affect cognition in Major Depressive Disorder (MDD), we evaluated medication-naïve patients with MDD, medicated patients with MDD receiving the Selective Serotonin Reuptake Inhibitors (SSRI) paroxetine, and healthy controls. All three groups were administered a computer-based cognitive task with two phases, an initial phase in which a sequence is learned through reward-based feedback (which our prior studies suggest is striatal-dependent), followed by a generalization phase that involves a change in the context where learned rules are to be applied (which our prior studies suggest is hippocampal-region dependent). Medication-naïve MDD patients were slow to learn the initial sequence but were normal on subsequent generalization of that learning. In contrast, medicated patients learned the initial sequence normally, but were impaired at the generalization phase. We argue that these data suggest (i) an MDD-related impairment in striatal-dependent sequence learning which can be remediated by SSRIs and (ii) an SSRI-induced impairment in hippocampal-dependent generalization of past learning to novel contexts, not otherwise seen in the medication-naïve MDD group. Thus, SSRIs might have a beneficial effect on striatal function required for sequence learning, but a detrimental effect on the hippocampus and other medial temporal lobe structures critical for generalization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation
Sahay, A., Scobie, K. N., Hill, A. S., O'Carroll, C. M., Kheirbek, M. A., Burghardt, N. S., Fenton, A. A., Dranovsky, A., & Hen, R. (2011) · Nature · doi:10.1038/nature09817 · Cited by 1,567 · cited 1×
“Neuroimaging and animal studies suggest that SSRIs increase the size of the hippocampus by augmenting the rate of neurogenesis in the dentate gyrus, a substructure of the hippocampal region (Boldrini et al., 2009; Malberg and Schechter, 2005; Sahay et al., 2011).”
The role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244 · cited 4×
“urnal of Affective Disorders recent imaging studies suggest that patients with MDD show cognitive and neurochemical dysfunction directly related to the nigrostriatal system (Dunlop and Nemeroff, 2007; Robinson et al., 2012; Walter et al., 2007).”
InfluentialCourse of illness, hippocampal function, and hippocampal volume in major depression
MacQueen, G. M., Campbell, S., McEwen, B. S., Macdonald, K., Amano, S., Joffe, R. T., Nahmias, C., & Young, L. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337481100 · Cited by 980 · cited 1×
“This finding is important because patients with MDD are also thought to have a smaller-than-average hippocampus, a key brain region for memory formation located within the medial temporal lobe (Campbell and Macqueen, 2004; MacQueen et al., 2003; Vakili et al., 2000; Vythilingam et al., 2004).”
Antidepressants increase neural progenitor cells in the human hippocampus
Boldrini, M., Underwood, M. D., Hen, R., Rosoklija, G. B., Dwork, A. J., John Mann, J., & Arango, V. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.75 · Cited by 686 · cited 1×
“Neuroimaging and animal studies suggest that SSRIs increase the size of the hippocampus by augmenting the rate of neurogenesis in the dentate gyrus, a substructure of the hippocampal region (Boldrini et al., 2009; Malberg and Schechter, 2005; Sahay et al., 2011).”
Lorenzetti, V., Allen, N. B., Fornito, A., & Yücel, M. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.11.021 · Cited by 553
Hippocampal volume, memory, and cortisol status in major depressive disorder: Effects of treatment
Vythilingam, M., Vermetten, E., Anderson, G. M., Luckenbaugh, D., Anderson, E. R., Snow, J., Staib, L. H., Charney, D. S., & Bremner, J. D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.04.002 · Cited by 477
Serotonin and dopamine: unifying affective, activational, and decision functions.
Cools, R., Nakamura, K., & Daw, N. D. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.121 · Cited by 464
FOGEL, S., SMITH, C., & COTE, K. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.02.037 · Cited by 246 · cited 2×
“, 1990), which impairs hippocampal-, but not striatal-dependent learning (Fogel et al., 2007; Hennevin et al., 1995; Hennevin et al., 2007; Watts et al., 2012).”
Robinson, O. J., Cools, R., Carlisi, C. O., Sahakian, B. J., & Drevets, W. C. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010137 · Cited by 232
Cited by
Barch, D. M., Pagliaccio, D., & Luking, K. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_376 · Cited by 218
Baune, B. T., & Renger, L. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.05.013 · Cited by 115
“…study showed a detrimental effect of Paroxetine on the hippocampus and other medial temporal lobe structures which are critical for generalization of learned material (Herzallah et al., 2013c), suggesting antagonistic effects of this antidepressant on neural process and broader brain functions.”
BackgroundResultInfluentialLi, Y., Abdourahman, A., Tamm, J. A., Pehrson, A. L., Sánchez, C., & Gulinello, M. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.05.013 · Cited by 79
“, 2011) and that cognitive deficits in depressed and/ or elderly patients are also relatively insensitive to SSRI treatment (Herzallah et al., 2013).”
Herzallah, M. M., Moustafa, A. A., Natsheh, J. Y., Abdellatif, S. M., Taha, M. B., Tayem, Y. I., Sehwail, M. A., Amleh, I., Petrides, G., Myers, C. E., et al. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00067 · Cited by 77
Self-citationThe impact of cognitive challenges in major depression: the role of the primary care physician
Mattingly, G., Anderson, R. H., Mattingly, S. G., & Anderson, E. Q. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1221318 · Cited by 24
Metadata
- Authors
- Herzallah, M. M., Moustafa, A. A., Natsheh, J. Y., Danoun, O. A., Simon, J. R., Tayem, Y. I., Sehwail, M. A., Amleh, I., Bannoura, I., Petrides, G., Myers, C. E., & Gluck, M. A.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 151
- Issue
- 2
- Pages
- 484-492
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2103338502
- Cited by
- 29
- References
- 14
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder. https://app.cochat.ai/papers/10.1016/j.jad.2013.06.030
- The paper
- Herzallah, M. M., Moustafa, A. A., Natsheh, J. Y., Danoun, O. A., Simon, J. R., Tayem, Y. I., Sehwail, M. A., Amleh, I., Bannoura, I., Petrides, G., Myers, C. E., & Gluck, M. A. (2013). Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2013.06.030
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.